Back
Invesco Biotechnology & Genome ETF 10K Form
Buy
62
PBE
Invesco Biotechnology & Genome ETF
Last Price:
71.45
Seasonality Move:
5.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PBE News And Ratings
See the #1 stock for the next 7 days that we like better than PBE
PBE Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Invesco Biotechnology & Genome ETF Earnings Forecast
Key Invesco Biotechnology & Genome ETF Financial Ratios
Invesco Biotechnology & Genome ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSEARCA |
|---|---|
| Current Symbol: | PBE |
| CUSIP: | 46137V |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PBE Technical Analysis vs Fundamental Analysis
Buy
62
Invesco Biotechnology & Genome ETF (PBE)
is a Buy
Is Invesco Biotechnology & Genome ETF a Buy or a Sell?
-
Invesco Biotechnology & Genome ETF stock is rated a Buy
The current Invesco Biotechnology & Genome ETF [PBE] share price is $70.76. The Score for PBE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.